SHL Telemedicine Ltd.

Equities

SHLTN

IL0010855885

Healthcare Facilities & Services

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
4.75 CHF -2.06% Intraday chart for SHL Telemedicine Ltd. -2.06% -31.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
SHL Telemedicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : SHL Telemedicine Ltd., 2023 Earnings Call, Apr 17, 2024
SHL Telemedicine Logs Revenue Growth in FY23 MT
SHL Telemedicine Reports Wider FY23 Attributable Loss MT
SHL Telemedicine Ltd. Announces Full Results of the Imperial College London Tele-ACS Trial CI
SHL Telemedicine's SmartHeart Technology Triumphs in US Army Project Convergence - Capstone 4 Experiment CI
SHL Telemedicine Ltd. Announces Erez Nachtomy, to Steps Down as CEO in Mid-June 2024 CI
SHL Telemedicine Ltd Provides Information to Shareholders CI
Value Base Ltd Provides Information to Shareholders of SHL Telemedicine CI
SHL Telemedicine Ltd. Announces Board Changes CI
SHL Telemedicine Ltd. Announces Board Changes CI
Danbar Finance Nominates a Candidate to the Board of SHL Telemedicine CI
Value Base Ltd Sends Letter to SHL Telemedicine Ltd CI
SHL Telemedicine Establishes Cardiology Network in US with HeartNexus MT
SHL Telemedicine Advances Direct-to-Consumer Strategy in US for At-Home ECG Technology MT
Shl Telemedicine Ltd. Announces the Initial Results from the Mayo Clinic Help-Mi and the Imperial College London Tele-Acs Trials CI
Transcript : SHL Telemedicine Ltd., H1 2023 Earnings Call, Sep 21, 2023
SHL Telemedicine Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
SHL Telemedicine Swings to H1 Loss; Revenue Shrinks MT
SIX Group Makes Index Adjustments Following Review MT
SHL Telemedicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
SHL Telemedicine Ltd.(NasdaqCM:SHLT) added to NASDAQ Composite Index CI
SHL Telemedicine Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
SHL Telemedicine Ltd. Signs Partnership with White Rock Medical Center for Use of Smartheart® CI
SHL Telemedicine Ltd. Appoints Kimberly J. Henderson and Joshua H. Atkins to its US Advisory Board CI
Chart SHL Telemedicine Ltd.
More charts
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SHLTN Stock
  4. News SHL Telemedicine Ltd.
  5. SHL Telemedicine Advances Direct-to-Consumer Strategy in US for At-Home ECG Technology